Skip to main content
logo
Vivanza Biosciences Limited (BOM:530057)
India flag India · Delayed Price · Currency is INR
1.940
+0.130 (7.18%)
At close: Jul 28, 2026

Vivanza Biosciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
1,1601,16074.72278.89181.54111.99
Revenue Growth
1452.84%1452.84%-73.21%53.62%62.10%12.67%
Gross Profit
15.9615.966.5119.3916.4815.46
Operating Income
8.238.23-3.0511.0811.358.5
Net Income
3.943.94-6.745.475.983.33
Earnings Per Share
0.100.10-0.170.140.150.08
EPS Growth
----6.40%80.21%340.72%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
0.650.651.471.961.70.56
Total Debt
101.92101.9286.5251.779.9755.08
Net Cash (Debt)
-101.27-101.27-85.05-49.74-78.27-54.52
Net Cash Growth
------
Net Cash Per Share
-2.57-2.57-2.13-1.27-1.96-1.36

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-25.79-25.79-24.9920.44-9.4624.67
Capital Expenditures
-1.24-1.24-0.08-0.38--
Free Cash Flow
-27.03-27.03-25.0720.06-9.4624.67
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
1.38%1.38%8.71%6.95%9.08%13.80%
Operating Margin
0.71%0.71%-4.08%3.97%6.25%7.58%
Pretax Margin
0.47%0.47%-8.91%2.49%3.95%2.98%
Profit Margin
0.34%0.34%-9.02%1.96%3.30%2.97%
FCF Margin
-2.33%-2.33%-33.55%7.19%-5.21%22.03%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
19.4017.85-49.63125.69226.61
P/FCF Ratio
---13.54-30.59
PS Ratio
0.070.061.070.974.146.74